# Alto Ingredients, Inc.: overview ALTO · Nasdaq · CIK 778164 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/alto.md) · [Financials](/companies/alto/financials.md) · [Filings](/companies/alto/filings.md) · [Insiders](/companies/alto/insiders.md) Latest reported revenue: [$245.7m](/filings/0001213900-26-086336.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-086336). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [252](/filings/0001213900-25-107625.md) | [236 d](/filings/0001213900-26-027687.md) | [227](/filings/0001213900-26-053870.md) | [218](/filings/0001213900-26-086336.md) | [241](/filings/0001213900-25-107625.md) | [232 d](/filings/0001213900-26-027687.md) | [225](/filings/0001213900-26-053870.md) | [246](/filings/0001213900-26-086336.md) | | Gross margin | % | [2.4%](/filings/0001213900-25-107625.md) | [(0.6%) d](/filings/0001213900-26-027687.md) | [(0.8%)](/filings/0001213900-26-053870.md) | [(0.9%)](/filings/0001213900-26-086336.md) | [9.7%](/filings/0001213900-25-107625.md) | [6.5% d](/filings/0001213900-26-027687.md) | [4.1%](/filings/0001213900-26-053870.md) | [6.8%](/filings/0001213900-26-086336.md) | | Operating margin | % | [(0.3%)](/filings/0001213900-25-107625.md) | [(16.6%) d](/filings/0001213900-26-027687.md) | [(4.0%)](/filings/0001213900-26-053870.md) | [(3.7%)](/filings/0001213900-26-086336.md) | [7.0%](/filings/0001213900-25-107625.md) | [3.2% d](/filings/0001213900-26-027687.md) | [1.1%](/filings/0001213900-26-053870.md) | [3.5%](/filings/0001213900-26-086336.md) | | Net margin | % | [(1.0%)](/filings/0001213900-25-107625.md) | [(17.6%) d](/filings/0001213900-26-027687.md) | [(5.2%)](/filings/0001213900-26-086336.md) | [(5.0%)](/filings/0001213900-26-086336.md) | [5.9%](/filings/0001213900-25-107625.md) | [9.4% d](/filings/0001213900-26-027687.md) | [1.9%](/filings/0001213900-26-086336.md) | [4.8%](/filings/0001213900-26-086336.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0001213900-25-107625.md) | not reported | [(0.16)](/filings/0001213900-26-053870.md) | [(0.15)](/filings/0001213900-26-086336.md) | [0.19](/filings/0001213900-25-107625.md) | not reported | [0.05](/filings/0001213900-26-053870.md) | [0.15](/filings/0001213900-26-086336.md) | | Free cash flow | $m | [18.1 d](/filings/0001213900-25-107625.md) | [(11.1) d](/filings/0001213900-26-027687.md) | [(18.8)](/filings/0001213900-26-053870.md) | [(1.3) d](/filings/0001213900-26-086336.md) | [21.2 d](/filings/0001213900-25-107625.md) | [7.6 d](/filings/0001213900-26-027687.md) | [3.3](/filings/0001213900-26-053870.md) | [17.9 d](/filings/0001213900-26-086336.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,208](/filings/0001213900-24-022351.md) | [1,336](/filings/0001213900-25-023709.md) | [1,223](/filings/0001213900-26-027687.md) | [965](/filings/0001213900-26-027687.md) | [918](/filings/0001213900-26-027687.md) | | Gross margin | % | [5.6%](/filings/0001213900-24-022351.md) | [(2.1%)](/filings/0001213900-25-023709.md) | [1.3%](/filings/0001213900-26-027687.md) | [1.0%](/filings/0001213900-26-027687.md) | [3.8%](/filings/0001213900-26-027687.md) | | Operating margin | % | [3.3%](/filings/0001213900-24-022351.md) | [(4.6%)](/filings/0001213900-25-023709.md) | [(2.0%)](/filings/0001213900-26-027687.md) | [(5.4%)](/filings/0001213900-26-027687.md) | [0.8%](/filings/0001213900-26-027687.md) | | Net margin | % | [3.8%](/filings/0001213900-24-022351.md) | [(3.1%)](/filings/0001213900-25-023709.md) | [(2.3%)](/filings/0001213900-26-027687.md) | [(6.1%)](/filings/0001213900-26-027687.md) | [1.5%](/filings/0001213900-26-027687.md) | | Diluted EPS | $ per share | [0.61](/filings/0001213900-24-022351.md) | [(0.60)](/filings/0001213900-25-023709.md) | [(0.40)](/filings/0001213900-26-027687.md) | [(0.82)](/filings/0001213900-26-027687.md) | [0.16](/filings/0001213900-26-027687.md) | | Free cash flow | $m | [10.4](/filings/0001213900-24-022351.md) | [(31.7)](/filings/0001213900-25-023709.md) | [(7.5)](/filings/0001213900-26-027687.md) | [(14.6)](/filings/0001213900-26-027687.md) | [8.6](/filings/0001213900-26-027687.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/alto/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $31.3m | 5,495,025 | | Added +4,196,940 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $18.3m | 3,212,643 | | Added +32,432 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $13.0m | 2,280,128 | | Added +489,865 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $11.3m | 1,980,080 | | Added +1,088,965 | | [Hillsdale Investment Management Inc.](/funds/1368465.md) | 2026-06-30 | $9.7m | 1,703,703 | | Added +703,000 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $8.7m | 1,518,521 | | Reduced −155,136 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $7.0m | 1,230,173 | | Added +857,326 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $6.8m | 1,198,890 | | Reduced −807,870 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.5m | 1,143,740 | | Added +484,472 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $6.5m | 1,139,500 | Call | Reduced −564,300 | ## Recent filings [All 1,061 filings](/companies/alto/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 16:44 ET | [8-K](/filings/0001213900-26-086750.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-086750 | | 2026-08-07 | 20:59 ET | [10-Q](/filings/0001213900-26-086336.md) | Quarterly report, period 2026-06-30 | 0001213900-26-086336 | | 2026-08-05 | 16:18 ET | [8-K](/filings/0001213900-26-085686.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-085686 | | 2026-06-23 | 16:18 ET | [8-K](/filings/0001213900-26-071111.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-071111 | | 2026-05-08 | 16:06 ET | [10-Q](/filings/0001213900-26-053870.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053870 | | 2026-05-06 | 16:25 ET | [8-K](/filings/0001213900-26-052830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-052830 | | 2026-04-30 | 17:09 ET | [DEF 14A](/filings/0001213900-26-050384.md) | Proxy statement, period 2026-06-23 | 0001213900-26-050384 | | 2026-03-13 | 16:16 ET | [10-K](/filings/0001213900-26-027687.md) | Annual report, period 2025-12-31 | 0001213900-26-027687 | | 2026-03-04 | 16:11 ET | [8-K](/filings/0001213900-26-023650.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-023650 | | 2025-11-26 | 08:45 ET | [8-K](/filings/0001213900-25-115108.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-115108 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-027687.md), filed Mar 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/f5d1653d-c586-4320-b116-e88983b9f035) ## About the filer - CIK: 778164 - Tickers: ALTO - Exchange: Nasdaq - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.